Screener
ClearPoint Neuro CLPT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
FAQ
- What is ClearPoint Neuro's EPS (diluted)?
- ClearPoint Neuro (CLPT) reported EPS (diluted) of -$0.32 in Q1 2026.
- How has ClearPoint Neuro's EPS (diluted) changed year-over-year?
- ClearPoint Neuro's EPS (diluted) decreased by 45.5% year-over-year, from -$0.22 to -$0.32.
- What is the long-term trend for ClearPoint Neuro's EPS (diluted)?
- Over 4 years (2021 to 2025), ClearPoint Neuro's EPS (diluted) has grown at a 8.0% compound annual growth rate (CAGR), from -$0.67 to -$0.91.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about ClearPoint Neuro's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude